Literature DB >> 32934051

Lessons of the month: Pyroglutamic acidosis: long-term paracetamol and a high anion gap.

Emma Trevor-Jones1, Lewis T Hughes2, Rebecca Robson1, Alan Bromley1, Gordon W Stewart3.   

Abstract

An 84-year-old woman presented in extremis with confusion and Kussmaul respiration. She had a history of urosepsis, renal impairment and osteoarthrosis. The venous blood gas showed a marked metabolic acidosis with a high anion gap. Lactate and ketones were normal. Her medications included regular paracetamol via a dosette box. Lactic acidosis and ketoacidosis being excluded, it emerged that the most likely cause of a high anion-gap acidosis in the presence of chronic paracetamol therapy is pyroglutamic acidosis, caused by the build-up of an acidic intermediate in the gamma-glutamyl cycle, the function of which is to synthesise glutathione. Paracetamol was stopped and fluids administered; she recovered over 7 days and was sent home. The biochemical diagnosis was confirmed by a central laboratory after discharge. This case emphasises the importance of the anion gap in diagnosis, and one important danger of chronic paracetamol administration. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  Pyroglutamic acidosis; anion gap; paracetamol

Mesh:

Substances:

Year:  2020        PMID: 32934051      PMCID: PMC7539707          DOI: 10.7861/clinmed.2020-0363

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  7 in total

1.  New-onset diabetes mellitus associated with the initiation of quetiapine treatment.

Authors:  M Sobel; E D Jaggers; M A Franz
Journal:  J Clin Psychiatry       Date:  1999-08       Impact factor: 4.384

2.  Atypical pyroglutamic aciduria: possible role of paracetamol.

Authors:  J J Pitt; G K Brown; V Clift; J Christodoulou
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Association between paracetamol and pyroglutamic aciduria.

Authors:  J Pitt
Journal:  Clin Chem       Date:  1990-01       Impact factor: 8.327

4.  Pyroglutamic acidosis in association with therapeutic paracetamol use.

Authors:  Robert W Hunter; Cate Lawson; Evangelia Galitsiou; Fiona Gifford; John J Neary
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

Review 5.  Physiological approach to assessment of acid-base disturbances.

Authors:  Kenrick Berend; Aiko P J de Vries; Rijk O B Gans
Journal:  N Engl J Med       Date:  2014-10-09       Impact factor: 91.245

6.  Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione.

Authors:  J R Mitchell; D J Jollow; W Z Potter; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

Review 7.  Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle.

Authors:  Michael Emmett
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

  7 in total
  2 in total

1.  Transformation: fighting the past or building the new?

Authors:  Anton Emmanuel
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

Review 2.  Severe Anion Gap Metabolic Acidosis Resulting from Combined Chronic Acetaminophen Toxicity and Starvation Ketosis: A Case Report and Literature Review.

Authors:  Thomas Kalinoski
Journal:  Am J Case Rep       Date:  2022-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.